Nosocomial infection
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- An infection acquired in a hospital or other healthcare setting.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Nosocomial infection
- Therapeutic area
- Infectious Disease
- nosocomial infection
- HAI
- Healthcare-associated infection
- hospital-acquired infection
- hospital-onset infection
- nosocomial infection
- nosocomial infectious disease
- Cross infections
- Healthcare associated infection
- Healthcare associated infections
- associated infection, Healthcare
- associated infections, Healthcare
- health care associated infection
- health care associated infections
- hospital infection
- hospital infections
- infection, Cross
- infection, Healthcare associated
- infection, hospital
- infection, nosocomial
- infections, Cross
- infections, Healthcare associated
- infections, hospital
- infections, nosocomial
- nosocomial infections
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Unknown
- MONDO ID
- MONDO:0043544
- Parent condition
- MONDO:0005550
Related records
Broader conditions (6)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Iatrogenic disease
- Infectious disease
Narrower conditions (3)
- Iatrogenic botulism
- Iatrogenic Creutzfeldt-Jakob disease
- Iatrogenic Kaposi's sarcoma
Trials (290)
- 4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings
- A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization
- A Multi-level Antimicrobial Surface Coating for a Healthier Environment
- A Randomized Trial Comparing Matt and Antimicrobial Cellomed Laminates
- A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
- A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
- Achromobacter Xylosoxidans (ACHX) Infections
- Active Bathing to Eliminate Infection (ABATE Infection) Trial
- Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
- Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM
- Administration of a Lactobacillus GG and Vitamins Containing Mixture is Effective in Preventing Nosocomial Infection in Children
- Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
- AI-Driven Prediction of Hospital-Acquired Infections With EHR
- Alcohol Hand Gel Use in Mbale Regional Referral Hospital: a Cost Effectiveness Evaluation
- An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
- An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice
- An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers
- Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated From Patients With Hospital Acquired Infections in Sohag University Hospitals, Egypt
- Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
Approved drugs (2)
- Doripenem monohydrate
- Telavancin hydrochloride
Drugs in development (6)
- Chlorhexidine gluconate Phase 2
- Daptomycin Phase 3
- Glutamine Phase 2
- Maltodextrin Phase 2
- Vancomycin Phase 3
- Vancomycin hydrochloride Phase 3
Other linked drugs (2)
- Alcohol
- Lactulose